Determination of an active metabolite of prulifloxacin by HPLC and its pharmacokinetics
JIANG Haiyan,CHEN Kunming,QIU Xiangjun,HU Guoxin
DOI: https://doi.org/10.19577/j.cnki.issn10074406.2010.01.003
2010-01-01
Abstract:AIM To develop a HPLC method for the determination of NM394,an active metabolite of prulifloxacin in human plasma and carry out a in vivo pharmacokinetic study.METHODS A series of blood samples were collected from 10 healthy volunteers after oral administration of prulifloxacin tablets at a dose of 200 mg and were detected by HPLC.The plasma protein was precipitated by perchloric acid and the analyte and internal standard were separated on an Agilent ZORBAX Eclipse XDB- C_(18)(150 mm×4.6 mm,5μm) column by acetonitrile,2%acetic acid and water with ratio of 20:40:40(V/V/V) at a flow of 0.8 mL·min~(-1) and detected at a wavelength of 278 nm.RESULTS Excellent linear relationship was obtained in the range of 0.05 - 7.50 mg·L~(-1)(r = 0.999 9) and the lower limit of quantitation was 0.05 mg·L~(-1).The relative recoveries(n = 5) were(105.16±1.86)%,(105.01±1.94)% and(100.40±4.53)%respectively at low,middle and high concentrations.The intra-day RSDs were 5.57%,2.36% and 2.31%,while the inter-day RSDs were 3.25%,2.22%and 4.26%,respectively.The main pharmacokinetic parameters were as follows:ρ_(max).480±0.329)mg·L~(-1),t_(max)(0.825±0.374)h,AUC_((0→t))(6.853±1.679)mg·h·L~(-1) and AUC_((0→∞))(7.488±1.687)mg·h·L~(-1).CONCLUSION The method developed in this study is of high sensitivity, good selectivity and reproducibility for accurate determination of NM394 in human plasma.